Absorption |
Blood-Brain Barrier | BBB+ | 0.5482 |
Human Intestinal Absorption | HIA+ | 0.9358 |
Caco-2 Permeability | Caco2+ | 0.9020 |
P-glycoprotein Substrate | Substrate | 0.5630 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9679 |
Non-inhibitor | 0.9513 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9026 |
Distribution |
Subcellular localization | Mitochondria | 0.5694 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7189 |
CYP450 2D6 Substrate | Non-substrate | 0.9014 |
CYP450 3A4 Substrate | Non-substrate | 0.6705 |
CYP450 1A2 Inhibitor | Inhibitor | 0.7511 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.7467 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9402 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8813 |
CYP450 3A4 Inhibitor | Inhibitor | 0.7556 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6794 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9412 |
Non-inhibitor | 0.9415 |
AMES Toxicity | Non AMES toxic | 0.9133 |
Carcinogens | Non-carcinogens | 0.9347 |
Fish Toxicity | High FHMT | 0.7510 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8294 |
Honey Bee Toxicity | High HBT | 0.7609 |
Biodegradation | Not ready biodegradable | 0.6725 |
Acute Oral Toxicity | III | 0.8271 |
Carcinogenicity (Three-class) | Non-required | 0.5806 |